BTBD9 is a novel component of IGF signaling and regulates manganese-induced dopaminergic dysfunction
Pan Chen, Fuli Zheng, Shaojun Li, Hong Cheng, Julia Bornhorst, Yunhui Li, Bobo Yang, Kun He Lee, Tao Ke, Tanja Schwerdtle, Xiaobo Yang, Aaron B. Bowman, Michael Aschner
The paper identifies BTBD9 as a novel component of IGF signaling that mitigates manganese-induced dopaminergic dysfunction in multiple species.
bioRxiv · Feb 18, 2021 · PreprintNeuroscience